Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Annemarie R. Thornton"'
Autor:
Lisa Lupinacci, Eliav Barr, Janine T. Bryan, Kristjan Sigurdsson, Susanne K. Kjaer, Teresa M. Hesley, Finn Egil Skjeldestad, Mauricio Hernández-Ávila, Annemarie R. Thornton, Joakim Dillner, John W. Boslego, Luisa L. Villa, Nubia Muñoz, Evan R. Myers, Steinar Thoresen, Gonzalo Perez, Sven Eric Olsson, Heather L. Sings, Christine K. Gause, Matti Lehtinen, Slawomir Majewski, F. Xavier Bosch, Mark T. Esser, Frank J. Taddeo, Jorma Paavonen, Kevin A. Ault, Patricia J. Garcia, Laura A. Koutsky, Darron R. Brown, Robert J. Kurman, Daron G. Ferris, Hseon Tay Eng
Publikováno v:
New England Journal of Medicine. 356:1915-1927
Human papillomavirus types 16 (HPV-16) and 18 (HPV-18) cause approximately 70% of cervical cancers worldwide. A phase 3 trial was conducted to evaluate a quadrivalent vaccine against HPV types 6, 11, 16, and 18 (HPV-6/11/16/18) for the prevention of
Autor:
Iain B. Squire, Thao Huynh, Lawrence I. Deckelbaum, Pierre Laramée, Simon Weber, Pierre Théroux, Katherine E Harris, Annemarie R Thornton, Harvey D. White, Marc Cohen, Man-Wai Lo, Jean G. Diodati, Steven Borzak, Frederic L. Sax
Publikováno v:
International Journal of Cardiology. 71:273-281
Background: Tirofiban, an intravenous glycoprotein IIb/IIIa antagonist, and enoxaparin, a low molecular weight heparin, have each been shown to be effective at reducing cardiac ischemic events compared to unfractionated heparin alone in separate tria
Autor:
Teresa M. Hesley, Mauricio Hernández-Ávila, Luisa L. Villa, Daron G. Ferris, Annemarie R. Thornton, Nubia Muñoz, Margaret James, Laura A. Koutsky, Radha Railkar, Robert J. Kurman, Steinar Thoresen, Carlos Sattler, Gonzalo Perez, Evan R. Myers, Hseon Tay Eng, Eliav Barr, Susanne K. Kjaer, Mark T. Esser, Kevin A. Ault, Patricia J. Garcia, Kristjan Sigurdsson, Darron R. Brown, Ole Eric Iversen, Janine T. Bryan, Scott Vuocolo, Sven Eric Olsson, Joakim Dillner, Micki Nelson, Slawomir Majewski, Matti Lehtinen, Jorma Paavonen, John W. Boslego, F. Xavier Bosch, Frank J. Taddeo
Publikováno v:
The Journal of infectious diseases. 196(10)
Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV) L1 virus-like-particle (VLP) vaccine has been shown to be 95%-100% effective in preventing cervical and genital disease related to HPV-6,-11,-16, and-18 in 16-26-year-old